|
6 Companies |
|
2 Products |
|
2 Products |
|
1 Mechanism of Action |
|
0 Trials |
|
52 News |
|
| «12 |
- |||||||||| Typhim Vi (typhoid polysaccharide vaccine) / Sanofi
New P3 trial: A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults (clinicaltrials.gov) - Nov 6, 2011
P3, N=552, Completed, Sponsor: Novartis
- ||||||| Imojev (live attenuated Japanese encephalitis chimeric virus vaccine) / Sanofi
Trial completion: A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers (clinicaltrials.gov) - Oct 10, 2011
P3, N=300, Completed, Sponsor: Sanofi Pasteur, a Sanofi Company
Active, not recruiting --> Completed
- ||||| Ixiaro (IC51) / Valneva
Enrollment closed: Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country (clinicaltrials.gov) - Aug 31, 2011
P3, N=300, Active, not recruiting, Sponsor: Valneva Austria GmbH
Active, not recruiting --> Completed Recruiting --> Active, not recruiting